Infectious Disease Advisor news story
Compared with referral-based care, mobile telemedicine delivery of HCV treatment significantly improves treatment uptake and viral clearance among people who inject drugs in rural areas, according to study findings published in JAMA Network Open.
Investigators conducted an open-label, randomized, parallel-group clinical trial to assess whether integrating telemedicine-delivered direct-acting antiviral therapy with mobile syringe services could improve access to HCV care in underserved rural communities. Adults with chronic HCV infection and a history of injection drug use were recruited from 3 US rural counties.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.